• FSRC - World Hepatitis Day 2015: An Expert Interview with Mr. Theobald Owusu-Ansah

    There are almost 400 million people infected with viral hepatitis worldwide, and 4000 deaths per day attributed to the disease. As a part of FSRCs continued efforts to battle against viral hepatitis through health advocacy, FSRC interviewed an expert striving to curb the burden imposed by the disease in Ghana. Mr. Theobald Owusu-Ansah is the CEO and President of Theobald Hepatitis B Foundation and Hepatitis Coalition of Ghana. In addition, he is a Board Member of National Association of Hepatitis Taskforce, USA and a Patient Advisory Council Member, Hepatitis Foundation International, USA.

    Mr. Theobald shares valuable insights on taking pragmatic steps to manage hepatitis in countries that have lower awareness levels and bridge the gap between disease burden and effective action. He also suggests imperative actions to facilitate patient access to novel drugs and build an effective patient advocacy models or framework in emerging countries through collaborative approach.

    The key opinions generated from this interview video can be useful for any stakeholder joining to battle the dreadful disease called viral hepatitis.

  • FSRC WebClinic 2015: Building a National/Organizational Program for Diabetes by Dr. Nicky Lieberman

    As a part of our continued efforts to improve healthcare access, FSRC hosted a knowledge sharing session (webinar) on Building a National/Organizational Program for Diabetes by Dr. Nicky Lieberman. 

    Our eminent speaker for the webinar Dr. Nicky Lieberman has served successfully as the Medical Director of Clalit Medical Services (largest HMO in Israel and one of the largest worldwide) in Sharon-Shomron District, Israel. He led the way with crucial programs in risk management, quality assurance and disease management in the district. Currently, he is the Head of the Community Medical Division for diabetes. Also, he has been actively leading Clalit’s Diabetes Program, a disease management program for primary care to treat diabetes.

    Diabetes poses a universal threat with around 387 million people already affected across the world. This merely constitutes the tip of the iceberg as 46.3% individuals still remain undiagnosed. Hence, from a global health perspective, it has to be curtailed before it burgeons into a bigger menace. It is the obligation of each nation to start implementing healthcare strategies internally and then take it to the next level. 

    A national program is essential to provide a systematic and coordinated approach in improving the access to quality diabetes prevention, management and care. This requires elaborate and efficient planning, comprehensive policy shaping, advocacy and implementation.

    This webinar is a platform to learn and share approaches to plan, build and implement such national/organizational programs for comprehensive diabetes management in high and low-income countries.

  • FSRC Webinar: Leveraging Mobile Technology for Chronic Disease Prevention in Resource Limited Settings

    As a part of our continued efforts to improve awareness and patient access, FSRC hosted a knowledge-sharing Web-based seminar (webinar) on a key factor influencing healthcare access in emerging markets: mobile technology. This webinar, entitled “Leveraging Mobile Technology for Chronic Disease Prevention in Resource Limited Settings,” was presented by Dr. Nalini Saligram on the 27th of October 2014.

    Dr. Nalini, the CEO and founder of American nonprofit Arogya World, has contributed greatly to global health improvement, especially in preventing non-communicable diseases, through such programs as the 10,000 Women’s Global Survey, Every Woman Every Child, mDiabetes, Healthy Workplaces programs, and many more. Her organization, Arogya World, leverages global platforms to make a genuine difference on the ground. Specifically, the organization works toward improving the health and lives of people across the world. The organization is also a member of the NCD Alliance’s Common Interest Group and was a 2014 Drucker Award finalist.

    The webinar created a platform to learn and share approaches to utilizing mobile technology for chronic disease prevention in resource-limited settings. This is particularly relevant as mobile phone use is rapidly spreading across the developing world. The massive potential of mobile technology, particularly at the grassroots level, has barely been tapped (e.g., mhealth programs for health education). While voice and text messaging are still the most common applications of mobile technology, other potential uses include (but are not limited to) remote monitoring, data collection/transfer, and data analysis/management. Some of the key benefits of mobile technology include time savings, improved resource management, and the ability to reach remote audiences.

    The webinar would be of interest to those who wish to know more about mhealth and its applications, especially in health education and the prevention of chronic diseases and unhealthy practices such as smoking.  The 26 participants of this webinar were from a diverse set of countries, including Colombia, Ghana, India, Kenya, Nigeria, Singapore, Sweden, Tanzania, and Uganda.

  • Importance of Cost-effective Screening Methods of Hepatitis

    In this interview with FSRC, Prof. Dr. Mark Thursz (Professor of hepatology at The Imperial College and consultant in hepatology at St. Mary’s Hospital, London) outlines the importance of cost-effective screening methods of hepatitis at a national level. He states the importance of screening in resource constrained settings and the importance to link access to care and treatment post screening. Many people unaware of their hepatitis status remains a challenge in reducing the burden of hepatitis, Dr. Thursz mentions that addressing this issue is vital. He also emphasizes the importance of counselling at the time of diagnosis to the patient.

  • Lessons from Africa – Access

    In this interview with FSRC, Dr. Marina Alois Njelekela (Executive Director and Chair of the Department of Physiology at Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania) shares her view on the difference novel HCV drugs would make and the challenges of providing access to HCV treatment in Tanzania. She remarks on how the lessons learnt from the successful management of HIV in the African countries can be utilized for HCV: leveraging and integrating the existing HIV infrastructure towards providing streamlined HCV treatment and care. In addition, she mentions about the possible active stakeholders for the fight against viral hepatitis in Africa.

  • The Egyptian Model – Awareness Driven Change

    In this interview with FSRC, Dr. Mohamad Kamal Shaker [Prof. of Tropical Medicine and Hepatology and Vice Director of hepatocellular carcinoma (HCC) Unit at Ain Shams University, Cairo, Egypt] discusses the importance of demonstrating the link between HCV and HCC and the impact this has had on policy makers and stakeholders in Egypt: the high prevalence of hepatitis C driving the increasing incidence of HCC in Egypt. Furthermore, he mentions that due to the awareness of the same amongst policy makers and the Ministry of Health, established guidelines for the treatment of HCC in Egypt have been formed.

  • Barriers in accessing COPD care in Bulgaria

    In an interview with FSRC, Dr Hristo Metev, a Pulmonologist from Bulgaria talks about the barriers in ‘access to care’ for COPD (Chronic Obstructive Pulmonary Disease) patients in the region. In addition, he emphasizes the advantages of registries and clinical studies for patients in this region, helping them to keep abreast with the latest treatment options and care.

  • Elephant in the room - Diabetes in India

    This seven minute video is FSRC’s effort to encompass seven decades of diabetes research in India. We have tried to depict the evolution of research, potential influencers like policies, stakeholders, inventions and research activities overtime. We also plot the improved understanding of the disease burden based on nationwide studies.

  • The patient perspective to hepatitis in Uganda

    In an interview with FSRC, Mr Kenneth Kabagambe, President, The National Organisation for People Living with Hepatitis B, Uganda speak about the issues with access to care and the need for awareness campaigns in the country to ensure attention for hepatitis.

  • Hepatitis situation in Uganda

    In an interview with FSRC, Prof Ponsiano Ocama, President, Uganda Gastroenterology Society speak about the situation of hepatitis in Uganda and the elements that policy makers need to consider for shaping policy against hepatitis.

  • Hepatitis in Uganda - An overview

    In an interview with FSRC, Dr Emmanuel Seremba, Senior lecturer at the Department of Internal Medicine, Makerere University, College of Health Sciences, Kampala, Uganda talks about the problem of hepatitis in Uganda and the work currently being undertaken to combat the disease.

  • Drivers and barriers for collaboration for hepatitis

    In an interview with FSRC, Mr Theobald Owusu-Ansah talks about the drivers and barriers for collaboration in the fight against hepatitis. He also outlines the specific contributions that each stakeholder can make in the fight against hepatitis.

  • Raising awareness the key to create stakeholders against hepatitis

    In an interview with FSRC, Mr Theobald Owusu-Ansah talks about the importance of empowering the general population with information for prevention and general awareness of hepatitis.

  • Sustainability the key for success of hepatitis programs

    In an interview with FSRC, Mr Theobald Owusu-Ansah, President and CEO of Theobald Hepatitis B Foundation talks about the need for and the approach to create sustainable hepatitis programs in Ghana and the sub-Saharan Africa region.

  • Need for collaboration to combat hepatitis

    In an interview with FSRC, Mr Theobald Owusu-Ansah, President and CEO of Theobald Hepatitis B Foundation talks about the need for collaboration to combat hepatitis in Ghana and sub-Saharan Africa.

  • Hepatitis awareness in general public

    In an interview with FSRC, Mr Theobald Owusu-Ansah talks about the approaches that need to be adopted to raise awareness on hepatitis in the general population.

  • Hepatitis overview - Ghana

    In an interview with FSRC, Mr Theobald Owusu-Ansah talks about the overview of the hepatitis disease in Ghana and why it needs the attention that it does not get so-far.

    Disclaimer: The views expressed by the people interviewed in this section are their own and FSRC or phamax do not endorse the views and comments.